Please enable JavaScript to continue using this application.

Compare $COYA vs $XGN | Chartloom

Compare

$COYA vs $XGN

Coya Therapeutics Inc · Exagen Inc

COYA

Coya Therapeutics Inc

XGN

Exagen Inc

Compare $COYA vs $XGN

Comparing Coya Therapeutics Inc and Exagen Inc

COYACoya Therapeutics Inc

XGNExagen Inc

COYACoya Therapeutics Inc

Market cap

$116M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

35.49x

Rev growth (TTM)

1793.6%

YTD performance

-12.4%

52W performance

-21.6%

FCF yield

-15.3%

XGNExagen Inc

Market cap

$203M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.63x

Rev growth (TTM)

20.8%

YTD performance

39.4%

52W performance

-23.3%

FCF yield

-3.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COYA

XGN

Detailed metrics comparison

COYA

Coya Therapeutics Inc

XGN

Exagen Inc

Market Cap

COYA$116M

XGN$203M

Enterprise Value

COYA$73M

XGN$204M

Price

COYA$4.95

XGN$8.42

P/E Ratio

COYAN/A

XGNN/A

P/S Ratio

COYA14.48x

XGN2.86x

EV/Sales

COYA9.10x

XGN2.87x

EV/EBITDA

COYA0.00x

XGN0.00x

P/B Ratio

COYA2.61x

XGN16.60x

P/FCF Ratio

COYAN/A

XGNN/A

EV/FCF

COYA-4.10x

XGN-26.94x

PEG Ratio

COYAN/A

XGNN/A

Forward P/E (NTM)

COYAN/A

XGNN/A

Forward P/S (NTM)

COYA35.49x

XGN2.63x

Revenue (TTM)

COYA$8M

XGN$71M

Revenue Growth (YoY)

COYA1793.6%

XGN20.8%

Forward Rev Growth

COYA389.9%

XGN10.1%

Gross Margin (TTM)

COYA0.0%

XGN58.6%

Operating Margin (TTM)

COYA0.0%

XGN0.0%

EBITDA Margin (TTM)

COYA-259.8%

XGN-15.1%

Net Margin (TTM)

COYA-270.2%

XGN-26.6%

FCF Margin (TTM)

COYA-221.6%

XGN-10.7%

Net Income (TTM)

COYA$-22M

XGN$-19M

FCF (TTM)

COYA$-18M

XGN$-8M

EPS (TTM)

COYA-$0.92

XGN-$0.78

ROE (TTM)

COYA-5332.0%

XGN-12162.0%

ROA (TTM)

COYA-4748.0%

XGN-3368.0%

ROIC (TTM)

COYA-5332.0%

XGN-4566.0%

Cash

COYA$43M

XGN$25M

Debt

COYA$0

XGN$26M

Net Cash/Debt

COYA$43M

XGN$-959K

Current Ratio (TTM)

COYA13.40x

XGN3.18x

Quick Ratio (TTM)

COYA12.29x

XGN2.75x

Debt/Equity (TTM)

COYA0.00x

XGN2.09x

Debt/Assets (TTM)

COYA0.0%

XGN0.0%

Interest Coverage (TTM)

COYAN/A

XGNN/A

Net Debt/EBITDA (TTM)

COYA0.00x

XGN0.00x

Beta

COYA0.58

XGN2.28

52W Performance

COYA-21.6%

XGN-23.3%

YTD Performance

COYA-12.4%

XGN39.4%

% from 52W High

COYA-36.1%

XGN-31.2%

% from 52W Low

COYA33.4%

XGN225.1%

Asset Turnover (TTM)

COYA0.18x

XGN1.27x

FCF Yield (TTM)

COYA-15.3%

XGN-3.7%

Earnings Yield (TTM)

COYA-18.7%

XGN-9.3%

Dividend Yield (TTM)

COYAN/A

XGNN/A

Rule of 40

COYA1,571.9

XGN10.2

EV/GP/RG

COYAN/A

XGN0.55

Ticker research

View COYA research View XGN research

Metric	COYA Coya Therapeutics Inc	XGN Exagen Inc
Market & Valuation
Market Cap	$116M	$203M
Enterprise Value	$73M	$204M
Price	$4.95	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	14.48x	2.86x
EV/Sales	9.10x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.61x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.10x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	35.49x	2.63x
Revenue & Growth
Revenue (TTM)	$8M	$71M
Revenue Growth (YoY)	1793.6%	20.8%
Forward Rev Growth	389.9%	10.1%
Profitability
Gross Margin (TTM)	0.0%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-259.8%	-15.1%
Net Margin (TTM)	-270.2%	-26.6%
FCF Margin (TTM)	-221.6%	-10.7%
Net Income (TTM)	$-22M	$-19M
FCF (TTM)	$-18M	$-8M
EPS (TTM)	-$0.92	-$0.78
ROE (TTM)	-5332.0%	-12162.0%
ROA (TTM)	-4748.0%	-3368.0%
ROIC (TTM)	-5332.0%	-4566.0%
Financial Health
Cash	$43M	$25M
Debt	$0	$26M
Net Cash/Debt	$43M	$-959K
Current Ratio (TTM)	13.40x	3.18x
Quick Ratio (TTM)	12.29x	2.75x
Debt/Equity (TTM)	0.00x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	2.28
52W Performance	-21.6%	-23.3%
YTD Performance	-12.4%	39.4%
% from 52W High	-36.1%	-31.2%
% from 52W Low	33.4%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	1.27x
FCF Yield (TTM)	-15.3%	-3.7%
Earnings Yield (TTM)	-18.7%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,571.9	10.2
EV/GP/RG	N/A	0.55
Ticker research	View COYA research	View XGN research

Valuation

P/S Ratio

XGN

2.86x

COYA

14.48x

EV/FCF

XGN

-26.94x

COYA

-4.10x

Growth & revenue

Revenue Growth TTM

COYA

1793.6%

XGN

20.8%

Forward Revenue Growth

COYA

389.9%

XGN

10.1%

Profitability & performance

Gross Margin

XGN

58.6%

COYA

0.0%

ROE

COYA

-5332.0%

XGN

-12162.0%

FCF Yield %

XGN

-3.7%

COYA

-15.3%

52-Week Performance

COYA

-21.6%

XGN

-23.3%

Detailed metrics comparison

COYA

Coya Therapeutics Inc

XGN

Exagen Inc

Market Cap

COYA$116M

XGN$203M

Enterprise Value

COYA$73M

XGN$204M

Price

COYA$4.95

XGN$8.42

P/E Ratio

COYAN/A

XGNN/A

P/S Ratio

COYA14.48x

XGN2.86x

EV/Sales

COYA9.10x

XGN2.87x

EV/EBITDA

COYA0.00x

XGN0.00x

P/B Ratio

COYA2.61x

XGN16.60x

P/FCF Ratio

COYAN/A

XGNN/A

EV/FCF

COYA-4.10x

XGN-26.94x

PEG Ratio

COYAN/A

XGNN/A

Forward P/E (NTM)

COYAN/A

XGNN/A

Forward P/S (NTM)

COYA35.49x

XGN2.63x

Revenue (TTM)

COYA$8M

XGN$71M

Revenue Growth (YoY)

COYA1793.6%

XGN20.8%

Forward Rev Growth

COYA389.9%

XGN10.1%

Gross Margin (TTM)

COYA0.0%

XGN58.6%

Operating Margin (TTM)

COYA0.0%

XGN0.0%

EBITDA Margin (TTM)

COYA-259.8%

XGN-15.1%

Net Margin (TTM)

COYA-270.2%

XGN-26.6%

FCF Margin (TTM)

COYA-221.6%

XGN-10.7%

Net Income (TTM)

COYA$-22M

XGN$-19M

FCF (TTM)

COYA$-18M

XGN$-8M

EPS (TTM)

COYA-$0.92

XGN-$0.78

ROE (TTM)

COYA-5332.0%

XGN-12162.0%

ROA (TTM)

COYA-4748.0%

XGN-3368.0%

ROIC (TTM)

COYA-5332.0%

XGN-4566.0%

Cash

COYA$43M

XGN$25M

Debt

COYA$0

XGN$26M

Net Cash/Debt

COYA$43M

XGN$-959K

Current Ratio (TTM)

COYA13.40x

XGN3.18x

Quick Ratio (TTM)

COYA12.29x

XGN2.75x

Debt/Equity (TTM)

COYA0.00x

XGN2.09x

Debt/Assets (TTM)

COYA0.0%

XGN0.0%

Interest Coverage (TTM)

COYAN/A

XGNN/A

Net Debt/EBITDA (TTM)

COYA0.00x

XGN0.00x

Beta

COYA0.58

XGN2.28

52W Performance

COYA-21.6%

XGN-23.3%

YTD Performance

COYA-12.4%

XGN39.4%

% from 52W High

COYA-36.1%

XGN-31.2%

% from 52W Low

COYA33.4%

XGN225.1%

Asset Turnover (TTM)

COYA0.18x

XGN1.27x

FCF Yield (TTM)

COYA-15.3%

XGN-3.7%

Earnings Yield (TTM)

COYA-18.7%

XGN-9.3%

Dividend Yield (TTM)

COYAN/A

XGNN/A

Rule of 40

COYA1,571.9

XGN10.2

EV/GP/RG

COYAN/A

XGN0.55

Ticker research

View COYA research View XGN research

Metric	COYA Coya Therapeutics Inc	XGN Exagen Inc
Market & Valuation
Market Cap	$116M	$203M
Enterprise Value	$73M	$204M
Price	$4.95	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	14.48x	2.86x
EV/Sales	9.10x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.61x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.10x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	35.49x	2.63x
Revenue & Growth
Revenue (TTM)	$8M	$71M
Revenue Growth (YoY)	1793.6%	20.8%
Forward Rev Growth	389.9%	10.1%
Profitability
Gross Margin (TTM)	0.0%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-259.8%	-15.1%
Net Margin (TTM)	-270.2%	-26.6%
FCF Margin (TTM)	-221.6%	-10.7%
Net Income (TTM)	$-22M	$-19M
FCF (TTM)	$-18M	$-8M
EPS (TTM)	-$0.92	-$0.78
ROE (TTM)	-5332.0%	-12162.0%
ROA (TTM)	-4748.0%	-3368.0%
ROIC (TTM)	-5332.0%	-4566.0%
Financial Health
Cash	$43M	$25M
Debt	$0	$26M
Net Cash/Debt	$43M	$-959K
Current Ratio (TTM)	13.40x	3.18x
Quick Ratio (TTM)	12.29x	2.75x
Debt/Equity (TTM)	0.00x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	2.28
52W Performance	-21.6%	-23.3%
YTD Performance	-12.4%	39.4%
% from 52W High	-36.1%	-31.2%
% from 52W Low	33.4%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	1.27x
FCF Yield (TTM)	-15.3%	-3.7%
Earnings Yield (TTM)	-18.7%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,571.9	10.2
EV/GP/RG	N/A	0.55
Ticker research	View COYA research	View XGN research